Ken Griffin's position in Genmab is currently worth $60 Million. That's 0.06% of their equity portfolio (419th largest holding). The first Genmab trade was made in Q3 2019. Since then Ken Griffin bought shares 32 more times and sold shares on 22 occasions. The investor's estimated purchase price is $80.2 Million, resulting in a loss of 25%.